Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
Author:
Affiliation:
1. Department of Nephrology; Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine; Shanghai China
2. Department of Emergency; Putuo Hospital; Shanghai University of Traditional Chinese Medicine; Shanghai China
Funder
Xinhua Hospital
Publisher
Wiley
Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12629/fullpdf
Reference37 articles.
1. Diabetic nephropathy: protective factors and a new therapeutic paradigm;Mima;J Diabetes Complications,2013
2. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management;Buren;Adv Chronic Kidney Dis,2011
3. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review;Mavrakanas;Eur J Intern Med,2014
4. Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats;Ahn;Diabetes Metab J,2012
5. Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease;Lian;Nephrol Dial Transplant,2012
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Has the time come to step up to “triple therapy” for the treatment of diabetic kidney disease?;Diabetes Research and Clinical Practice;2023-07
2. Efficacy and Safety of Low-dose Spironolactone for Chronic Kidney Disease in Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2023-03-14
3. Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis;International Journal of Hypertension;2023-03-09
4. Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx;JCI Insight;2023-03-08
5. Shen-Qi-Jiang-Tang granule ameliorates diabetic nephropathy via modulating tumor necrosis factor signaling pathway;Journal of Ethnopharmacology;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3